Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2025-08-14 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于披露2025年半年度报告及摘要的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (417 characters) indicating that the company has approved its 2025 half-year report and summary, and that these reports will be disclosed on a specified website on August 15, 2025. It does not contain the actual financial data or the report itself, but rather informs investors about the upcoming publication of the interim report. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA), not as the Interim Report (IR) itself.
2025-08-14 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 半年度报告摘要' which translates to '2025 Semi-Annual Report Summary'. It contains financial data for the half-year period, including revenue, net profit, earnings per share, and shareholder information. The document explicitly states it is a summary of the half-year report and advises investors to read the full half-year report for comprehensive details. The length is 2819 characters, which is relatively short and consistent with a summary rather than a full report. However, the content includes substantive financial data and analysis for the half-year period, which aligns with the characteristics of an Interim / Quarterly Report (IR). It is not merely an announcement or a publication notice, nor is it a certification or a brief factsheet. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-14 Chinese
2025年半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 90% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the half-year period of 2025. It includes specific financial figures such as beginning balances, transaction amounts, interest, repayments, and ending balances. The document is titled as a '2025 Half-Year Non-Operating Fund Occupation and Other Related Fund Transactions Summary Table' and is prepared by the company with signatures from legal and accounting representatives. This indicates it is a financial report related to interim period financial data, specifically for half-year. The document length is 2415 characters, which is relatively short but contains substantive financial data and analysis for the half-year period. It is not an announcement or a certification but a financial summary report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-14 Chinese
监事会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of 阳普医疗科技股份有限公司 regarding the approval of the company's 2025 semi-annual report (半年度报告). It states that the supervisory board has reviewed and approved the 2025 semi-annual report and its summary, confirming the accuracy and completeness of the report. However, the document itself does not contain the financial statements or substantive financial data of the semi-annual report; instead, it references the report and summary with separate announcement numbers and directs readers to an external website for the full report. The document length is short (707 characters), and it serves as an official announcement of the supervisory board's resolution to approve the semi-annual report rather than the report itself. According to the "Menu vs Meal" rule, this is a Declaration of Voting Results & Voting Rights Announcement (DVA) type document because it reports the voting results of the supervisory board on the semi-annual report. Therefore, the correct classification is DVA with high confidence.
2025-08-14 Chinese
关于全资子公司取得药品生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding its wholly-owned subsidiary obtaining a pharmaceutical production license. It includes details about the license, its validity, and potential impact on the company. The document is short (747 characters) and serves as an official notice rather than a detailed report or financial statement. There is no financial data, no mention of annual or quarterly results, no management discussion, or other report types. It is a regulatory announcement about a licensing event, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-06-26 Chinese
关于全资子公司完成医疗器械质量管理体系认证证书变更及续期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its wholly-owned subsidiary completing the change and renewal of medical device quality management system certification certificates (ISO13485 and ISO9001). It details the certification scope, validity, and impact on the company. The document is short (1774 characters) and primarily serves as a formal announcement of certification updates rather than a detailed report or financial statement. There is no financial data, no regulatory form references, and no indication of a report being attached or published. This fits best into the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-05-16 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.